AZAndi Zhang

Andi Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andi Zhang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Ye

    Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Dongye Guo

    Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Haixia Hu

    Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Hao Wang

    Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Jichang Wu

    Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Mingliang Xiang

    Department of Otolaryngology & Head and Neck Surgery, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Excessive processing and acetylation of OPA1 aggravate age‐related hearing loss via the dysregulation of mitochondrial dynamics

    by Andi Zhang, Yi Pan, Hao Wang, Rui Ding, Tianyuan Zou, Dongye Guo, Yilin Shen, Peilin Ji, Weiyi Huang, Qing Wen, et al.

    The pathogenesis of age‐related hearing loss (ARHL) remains unclear. OPA1 is the sole fusion protein currently known to be situated in the inner mitochondrial membrane, which is pivotal for maintaining normal mitochondrial function. While it has already been demonstrated that mutations in OPA1 may lead to hereditary deafness, its involvement in the occurrence and development of ARHL has not been previously explored. In our study, we constructed D‐gal‐induced senescent HEI‐OC1 cells and the cochlea of C57BL/6J mice with a mutated SUMOylation site of SIRT3 using CRISPR/Cas9 technology. We found enhanced L‐OPA1 processing mediated by activated OMA1, and increased OPA1 acetylation resulting from reductions in SIRT3 levels in senescent HEI‐OC1 cells. Consequently, the fusion function of OPA1 was inhibited, leading to mitochondrial fission and pyroptosis in hair cells, ultimately exacerbating the aging process of hair cells. Our results suggest that the dysregulation of mitochondrial dynamics in cochlear hair cells in aged mice can be ameliorated by activating the SIRT3/OPA1 signaling. This has the potential to alleviate the senescence of cochlear hair cells and reduce hearing loss in mice. Our study highlights the significant roles played by the quantities of long and short chains and the acetylation activity of OPA1 in the occurrence and development of ARHL. This finding offers new perspectives and potential targets for the prevention and treatment of ARHL.